Conor Delaney, MD, PhD, MCh

Appointed
2015

Education & Fellowships

Fellowship - Cleveland Clinic
Colorectal Surgery
Cleveland, OH
2000

Fellowship - Royal College of Surgeons Ireland
General/Colorectal Surgery
Dublin, Ireland
1999

Graduate School - University College Dublin (National University of Ireland)
Masters in Surgery
Dublin,
1995

Graduate School - University College Dublin (National University of Ireland)
Dublin,
1994

Residency - Royal College of Surgeons Ireland
General Surgery
Dublin, Ireland
1993

Internship - Mater Misericordiade Hospital
Medicine/Surgery
Dublin,
1990

Medical Education - University College of Dublin, Faculty of Medicine
Medicine
Dublin,
1989

Certifications

• General Surgery - Colon and Rectal Surgery

Specialty Interests

laparoscopic colorectal surgery, carcinoma of the colon, rectum and anus, crohn's disease and ulcerative colitis, sphincter-saving surgery, reoperative abdominal surgery, colonoscopy

Awards & Honors

• 1987 Henderson Prize. Best undergraduate research, Mater Misericordiae Hospital.
• 1988 Leonard Prize. Best undergraduate dissertation at the Mater Misericordiae Hospital
• 1989 Gold Medal in Surgery. Final medical prize examination, Mater Misericordiae Hospital
• 1994 Ph.D. scholarship. Graduate School of Medicine, University of Pittsburgh.
• 1995 Ortho-Biotech Transplant Fellow. Best presentation at Annual Transplant Fellow’s Meeting, American Society of Transplant Physicians, New Orleans.
• 1996 European School of Oncology Fellowship
• 1997 Ethicon Foundation Travel Grant. Award to travel to RCSE - Pelvic Surgery course.
• 1998 Irish Travelling Fellowship. To Royal Society of Medicine, Section of Coloproctology.
• 1998 Ethicon Foundation Travel Grant
• 1999 Surgical Travelling Fellowship of the Royal College of Surgeons in Ireland
• 2000 Outstanding Clinical Fellow, Dept. Colorectal Surgery, Cleveland Clinic Foundation
• 2000 ‘KIWI’ Award - Best Endoscopist in Training. Dept. of Colorectal Surgery, Cleveland Clinic
• 2000 ACG/Astra Zeneca Senior Fellow Award. Amer. Coll. Gastroenterology, NY, Nov 2000.
• 2001 24th Millin Medal. Medal with named lectureship, Royal College of Surgeons in Ireland
• 2003 Best of the Best – 2002. Delaney CP et al, Ann Surg 2002; 236: 203-7 awarded as best colorectal paper of international literature by Archives of Surgery (2003; 138: 1266).
• 2004 Associacio Brasileira de Colite Ulcerativa e Doenca de Crohn (Brazilian Association for Ulcerative Colitis and Crohns Disease). Honorary Membership. Presented by Dr Flavio Steinwurz, San Paulo, May 6th, 2004.
• 2004 David Dunn Medal for best oral presentation. Awarded by the Association of Endoscopic Surgeons of Great Britain and Ireland, ASGBI Scientific Meeting, April 2004. “Conversion rates in laparoscopic colorectal surgery – a predictive model on 1253 patients”.
• 2004 New England Society of Colon and Rectal Surgeons Award for best oral presentation (presenter and first author). ASCRS May 2004. “Prospective, randomized, double-blind, multicenter, placebo-controlled study of alvimopan, a novel peripherally acting mu opioid receptor antagonist, for postoperative ileus after major abdominal surgery (Study 14CL302).”
• 2006 Colorectal Surgical Society of Australia and New Zealand. Honorary Membership. Presented by Dr Michael Levitt, Queenstown, Sept 29th, 2006.
• 2007 Northwest Society of Colon and Rectal Surgeons Award for best oral presentation (presenter; sole author). ASCRS 2007. “Outcome of discharge within 24-72 hours of laparoscopic colorectal surgery.”
• 2009 Inaugural Jeffrey L. Ponsky Professor of Surgical Education, Case Western Reserve University School of Medicine, Cleveland, Ohio
• 2009 Honorary Fellowship of the American Society of Colon and Rectal Surgeons
• 2011 Inaugural Murdough Master Clinician in Colorectal Surgery Award, University Hospitals Case Medical Center. Inaugural endowed Master Clinician Award.
• 2012 Mexican Society of Rectum and Colon Surgeons and Mexican College of Specialists in Coloproctology. Honorary International Fellowship.
• 2012 Midwest Surgical Association Best Paper Award for best oral presentation. “Extraction site incision and incisional hernias after laparoscopic colorectal surgery: Should we be avoiding the midline?”
• 2017 Victor W. Fazio Endowed Chair in Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio
• 2018 Sir Peter Freyer Memorial Medal, University College Galway, Ireland
• 2018 Honorary Fellowship of the Royal College of Surgeons, Ireland

Innovations & Patents

• “Anoscope for inspection and/or surgery.” US 8097002 B2. Issue date 1/17/2012. Chinese patent #: 200880017588.4 Issue date 12/16/2011
• “Headset with laser pointer”. US 9039224. Issue date 5/26/2015.
• “Method and System for Extraction and Analysis of Inpatient and Outpatient Encounters from One or More Healthcare Related Information Systems”. UH-Socrates™ Knowledge Management System. US Provisional Application Serial No. 61/443,853.
• “Subcutaneous hydration system, method and device”. US Provisional Application Serial No. 14/211,006.
• Socrates Analytics Inc. Founder. November 2011

See publications for Conor Delaney, MD, PhD, MCh.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/11/2024, Dr. Delaney has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.